G. Modorati et al., GLUCOSE-METABOLISM AND PATHOLOGICAL FINDINGS IN UVEAL MELANOMA - PRELIMINARY-RESULTS, Nuclear medicine communications, 17(12), 1996, pp. 1052-1056
The aims of this study were to assess the sensitivity of positron emis
sion tomography (PET) using [F-18]fluorodeoxyglucose (F-18-FDG) in the
detection of uveal melanoma, and to establish the relationship betwee
n pre-operative F-18-FDG uptake and a number of pathological features
of uveal melanoma. Twenty consecutive patients with a clinical diagnos
is of uveal melanoma were enrolled in the study. F-18-FDG uptake was a
ssessed in all subjects and the following parameters were assessed in
11 enucleated subjects: the mitotic index, the MIB-1 proliferating cel
l index, number of epithelioid cells, largest tumour diameter, tumoral
necrosis and inflammatory infiltration. Tumors with a diameter less t
han 7.5 mm were not detected by PET, possible because of limited spati
al resolution, and only 7 of 12 tumours with a diameter greater than 7
.5 mm were detected. With tumours greater than 7.5 mm in diameter, PET
and F-18-FDG allow two subgroups to be distinguished: those with high
and those with low glucose consumption. Apart from tumour size, F-18-
FDG uptake was not related to the pathological features examined. We h
ypothesize that F-18-FDG uptake may be related to the ratio of viable
to non-viable cells, or to the hypoxic cell fraction within the tumour
.